January 30, 2018 by Chain Drug Review
Alimentation Couche-Tard, Brunet, Eric La Flèche, François Coutu, Jean Coutu acquisition, Jean Coutu Group, McMahon Distributeur Pharmaceutique, Metro Inc.
Business, Leading Headlines, Retail News

MONTREAL — Metro Inc. has wrapped up financing for its $4.5 billion (Canadian) deal to acquire the Jean Coutu Group. The Canadian food and drug retailer updated the status of the Jean Coutu acquisition on Tuesday in reporting its fiscal 2018 first-quarter results. Metro said sales rose 4.7% year over year to $3.11 billion, while
December 11, 2017 by Bill Schiffner
François Coutu, Jean Coutu, Jean Coutu Group, Jean Coutu-Metro merger, McMahon Distributeur Pharmaceutique, Metro Inc.
2017, Issue 12-11-2017, Issues, News

MONTREAL — Jean Coutu Group shareholders have overwhelmingly approved the sale of the pharmacy chain to fellow Quebec retailer Metro Inc. A near-unanimous 99.9% of votes cast sanctioned the $4.5 billion transaction, which was well above the two-thirds requirement. Shareholders of Coutu are being offered a combination of cash and stock worth about $24.50 per
November 29, 2017 by Chain Drug Review
Brunet, François Coutu, Jean Coutu, Jean Coutu acquisition, Jean Coutu Group, McMahon Distributeur Pharmaceutique, Metro Inc.
Business, Leading Headlines, Retail News

MONTREAL — Jean Coutu Group shareholders have overwhelmingly approved the planned sale of the pharmacy chain to Quebec food and drug retailer Metro Inc. Jean Coutu said Wednesday that a near-unanimous 99.9% of votes cast sanctioned the $4.5 billion (Canadian) transaction, which was well above the two-thirds requirement. Under the Jean Coutu acquisition deal, the
October 23, 2017 by Geoff Walden and Chain Drug Review
Eric La Flèche, François Coutu, Jean Coutu, Jean Coutu Group, McMahon Distributeur Pharmaceutique, Metro Inc., Metro-Jean Coutu merger
2017, Issue 10-23-2017, Issues, News

MONTREAL — The acquisition of the Jean Coutu Group by Metro Inc. will create a $16 billion food and drug retailer with 1,307 stores in Quebec, Ontario and News Brunswick. Metro has agreed to purchase Coutu for $24.50 per share in cash and stock in a total deal valued at $4.5 billion ($3.6 billion U.S.).
October 2, 2017 by Chain Drug Review
Brunet, Eric La Flèche, François Coutu, Jean Coutu, Jean Coutu Group, McMahon Distributeur Pharmaceutique, Metro, Metro-Jean Coutu Group merger
2017, Business, Featured Articles, Issue 10-09-2017, Issues, Leading Headlines, News, Retail News

MONTREAL — Just days after confirming talks about a potential deal, Metro Inc. and the Jean Coutu Group have agreed to merge. The companies said Monday that Metro plans to acquire Jean Coutu Group for $24.50 per share in cash and stock in a total deal valued at $4.5 billion ($3.6 billion U.S.). Under the